An algorithm for investigating pulmonary hypertension (PH) using echocardiography. An algorithm for investigating pulmonary hypertension (PH) using echocardiography.

Slides:

Advertisements

Similar presentations

ASSESSMENT OF THE RIGHT VENTRICLE BY ECHOCARDIOGRAPHY.

Advertisements

LV axis model. ‘The 20 Views’ Annual Comprehensive Review & Update of Perioperative Echo.

Right Lung Left Lung.

Fig 39 Tetralogy of Fallot.

PATHOPHYSIOLOGY OF TRANSPOSITION OF THE ARTERIES (TGA)

Blood Flow Through the Heart. Right Lung Left Lung.

SPM 200 Clinical Skills Lab 1

Transposition of Great Arteries Parasternal long axis view from a patient with transposition of the great arteries. Note the two great arteries are parallel.

Normal anatomy at cardiac CT angiography

Two-dimensional echocardiogram from a patient with severe hypertrophic cardiomyopathy. There is a severe increase in left ventricular wall thickness, with.

Normal anatomy at cardiac CT angiography

The hemi-Mustard/bidirectional Glenn atrial switch procedure in the double-switch operation for congenitally corrected transposition of the great arteries:

Flow of the Blood Through the Heart

Nat. Rev. Cardiol. doi: /nrcardio

by Victor R. Gordeuk, Oswaldo L. Castro, and Roberto F. Machado

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Physiological changes in pulmonary arterial hypertension (PAH) patients which occur in response to pregnancy. Physiological changes in pulmonary arterial.

The ‘coronary artery sandwich anomaly’

Nat. Rev. Cardiol. doi: /nrcardio

Shafkat Anwar et al. BTS 2018;3:

Aortic Stenosis in Pregnancy: A Case Report

a) Normal parasternal long-axis view.

a) Measurement of the peak tricuspid regurgitant velocity

Circulatory/Respiratory Review

A 45-year-old with pulmonary hypertension

Circulatory/Respiratory Review

Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.

Familial history of hereditary haemorrhagic telangiectasis (HHT) of the 29-yr-old patient (•) with HHT and severe pulmonary arterial hypertension (PAH).

Severe pulmonary hypertension (PH) in interstitial lung disease (ILD) stepwise composite echocardiographic score. Severe pulmonary hypertension (PH) in.

Algorithm for the diagnosis and treatment of portopulmonary hypertension (POPH). Algorithm for the diagnosis and treatment of portopulmonary hypertension.

Line plots demonstrating the effect of increasing unavailability of tricuspid regurgitation on the echocardiographic score area under the curve (AUC) for.

Figure 6 The haemodynamic effects of

Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.

An algorithm for the early diagnosis of pulmonary arterial hypertension in systemic sclerosis. An algorithm for the early diagnosis of pulmonary arterial.

An expert proposal for a treat-to-target checklist for pulmonary arterial hypertension (PAH). An expert proposal for a treat-to-target checklist for pulmonary.

Computed tomography coronary angiogram from a 43-year-old female patient with pulmonary arterial hypertension, showing compression of the left coronary.

Reverse remodelling of left and right cavities under specific therapy in a patient with severe idiopathic pulmonary arterial hypertension. a) Before specific.

The hemi-Mustard/bidirectional Glenn atrial switch procedure in the double-switch operation for congenitally corrected transposition of the great arteries:

Peter Rosenberger, MD, Stanton K

Proposed screening algorithm for identification of pulmonary arterial hypertension (PAH) associated with connective tissue disease. Proposed screening.

A) Measurement of the right atrial a) area and b) long axis for calculation of right atrial volume. c) Measurement of the left ventricular eccentricity.

Model for the association between pathological features, physiological alterations and their association with pathological and clinical features. Model.

Proportion of patients in each World Health Organization functional class (WHO-FC) at the time of pulmonary arterial hypertension-associated systemic sclerosis.

Pulmonary angiography in the right lung (a, c, e and g) and the left lung (b, d, f and h) of a patient with chronic thromboembolic pulmonary hypertension.

Haemodynamic response to exercise in a) normal subjects and b) Fontan patients. Haemodynamic response to exercise in a) normal subjects and b) Fontan patients.

Rick A. Nishimura et al. JACC 2014;63:e57-e185

Prevalence of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) according to defect. Prevalence of pulmonary arterial.

Fontan circulation. a) Modified atriopulmonary connection Fontan in which the systemic venous atrium is directly connected to the pulmonary arteries; b)

Conceptual model of the ageing Fontan circulation

Implantation of a dual-chamber permanent pacemaker in a pregnant patient guided by intracardiac echocardiography and electroanatomic mapping Kelvin C.M.

Anatomical variations on a univentricular circulation

Cardiac magnetic resonance imaging of the heart in a patient with pulmonary arterial hypertension. a) Short axis image. #: dilated right ventricle; ¶:

Results of classification and regression tree analysis in patients with pulmonary hypertension-sickle cell disease. Results of classification and regression.

Kaplan–Meier survival curves for baseline cardiac magnetic resonance imaging variables according to the median value in patients with pulmonary hypertension.

A) Conventional pulmonary angiogram, with b) and c) corresponding optical coherence tomography images from a patient with chronic thromboembolic pulmonary.

Effect of pulmonary arterial hypertension (PAH) on SF-36-measured health-related quality of life (HRQoL) measures versus the normal population and other.

Tissue Doppler imaging (TDI) of the basal part of the right ventricle free wall allows the measurements on a single cardiac cycle of several parameters.

Representative echocardiographic findings: women with HDP versus women with NCP. †P

A) Annual diagnosed incidence of pulmonary embolism (PE), and b) annual full incidence of chronic thromboembolic pulmonary hypertension (CTEPH) per 100 000.

A) Longitudinal incision in the right pulmonary artery, exposed between the superior vena cava and aorta. b) Developing the endarterectomy dissection plane.

Survival rates in older (>65 years) compared with younger (18–65 years) patients with idiopathic pulmonary arterial hypertension. a) Expected ( )

A–c) Chest computed tomography excluding acute lung embolism and parenchymal lung disease and d–g) echocardiography performed during diagnostic work-up.

Diagnostic algorithm for chronic thromboembolic pulmonary hypertension

Schematic representations of pulmonary hypertension.

Simplified screening protocol for handheld devices for evaluation of heart diseases in adults, consisting of 14 images (seven views): 10 loops and four.

Pulmonary artery pressure in a) healthy subjects and b) pulmonary hypertension (PH) subjects. Pulmonary artery pressure in a) healthy subjects and b) pulmonary.

Baseline New York Heart Association functional class (NYHA FC) predicts survival in patients with pulmonary hypertension using infused epoprostenol therapy.

Treatment algorithm for chronic thromboembolic pulmonary hypertension.

Effect of placebo (n=88) and bosentan (n=80) on the co-primary end-point pulmonary vascular resistance (PVR) in the EARLY (Endothelial Antagonist Trial.

Presentation transcript:

An algorithm for investigating pulmonary hypertension (PH) using echocardiography. An algorithm for investigating pulmonary hypertension (PH) using echocardiography. TRV: tricuspid regurgitant velocity; PRV: pulmonary regurgitant velocity; RV: right ventricle; LV left ventricle; PLAX: parasternal long axis; RVOT: right ventricular outflow tract; AT: acceleration time; TAPSE: tricuspid annular plane systolic excursion; IVRT: isovolumic relaxation time; IVC: inferior vena cava; RA: right atrium. #: in patients >60 yrs of age, a TRV ≥2.9 m·s−1 is used as a cut-off value [13]. Luke S. Howard et al. Eur Respir Rev 2012;21:239-248 ©2012 by European Respiratory Society